VIRBAC SA (VIRP.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:VIRP - FR0000031577 - Common Stock
352 EUR
-2.5 (-0.71%)
Taking everything into account, VIRP scores 5 out of 10 in our fundamental rating. VIRP was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of VIRP get a neutral evaluation. Nothing too spectacular is happening here. VIRP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year VIRP was profitable.
VIRP had a positive operating cash flow in the past year.
VIRP had positive earnings in each of the past 5 years.
Each year in the past 5 years VIRP had a positive operating cash flow.
1.2 Ratios
VIRP has a Return On Assets of 8.00%. This is in the better half of the industry: VIRP outperforms 64.81% of its industry peers.
VIRP has a Return On Equity (13.64%) which is comparable to the rest of the industry.
VIRP's Return On Invested Capital of 11.47% is in line compared to the rest of the industry. VIRP outperforms 57.41% of its industry peers.
VIRP had an Average Return On Invested Capital over the past 3 years of 12.40%. This is in line with the industry average of 13.79%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROIC | 11.47% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
1.3 Margins
VIRP has a Profit Margin (10.40%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of VIRP has grown nicely.
VIRP has a Operating Margin (16.39%) which is in line with its industry peers.
In the last couple of years the Operating Margin of VIRP has grown nicely.
VIRP has a Gross Margin (67.10%) which is in line with its industry peers.
In the last couple of years the Gross Margin of VIRP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% |
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), VIRP is creating some value.
Compared to 1 year ago, VIRP has about the same amount of shares outstanding.
The number of shares outstanding for VIRP has been reduced compared to 5 years ago.
VIRP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.69 indicates that VIRP is not in any danger for bankruptcy at the moment.
VIRP's Altman-Z score of 4.69 is fine compared to the rest of the industry. VIRP outperforms 68.52% of its industry peers.
The Debt to FCF ratio of VIRP is 3.65, which is a good value as it means it would take VIRP, 3.65 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VIRP (3.65) is comparable to the rest of the industry.
VIRP has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VIRP (0.22) is better than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.65 | ||
| Altman-Z | 4.69 |
ROIC/WACC1.48
WACC7.74%
2.3 Liquidity
A Current Ratio of 1.96 indicates that VIRP should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.96, VIRP is doing good in the industry, outperforming 70.37% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that VIRP should not have too much problems paying its short term obligations.
VIRP has a Quick ratio of 1.04. This is in the better half of the industry: VIRP outperforms 64.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
VIRP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.61%, which is quite impressive.
The Earnings Per Share has been growing by 23.20% on average over the past years. This is a very strong growth
Looking at the last year, VIRP shows a quite strong growth in Revenue. The Revenue has grown by 12.07% in the last year.
The Revenue has been growing by 8.29% on average over the past years. This is quite good.
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
3.2 Future
VIRP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
VIRP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.53% yearly.
EPS Next Y3.93%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPS Next 5Y10.81%
Revenue Next Year4.62%
Revenue Next 2Y4.99%
Revenue Next 3Y5.17%
Revenue Next 5Y5.53%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.30, which indicates a rather expensive current valuation of VIRP.
The rest of the industry has a similar Price/Earnings ratio as VIRP.
Compared to an average S&P500 Price/Earnings ratio of 26.57, VIRP is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 16.59, the valuation of VIRP can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as VIRP.
VIRP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.3 | ||
| Fwd PE | 16.59 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VIRP indicates a somewhat cheap valuation: VIRP is cheaper than 62.96% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as VIRP.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.16 | ||
| EV/EBITDA | 10.72 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VIRP does not grow enough to justify the current Price/Earnings ratio.
VIRP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.16
PEG (5Y)0.88
EPS Next 2Y7.72%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
VIRP has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 2.37, VIRP has a dividend in line with its industry peers.
With a Dividend Yield of 0.41, VIRP pays less dividend than the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
8.36% of the earnings are spent on dividend by VIRP. This is a low number and sustainable payout ratio.
DP8.36%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPA:VIRP (12/24/2025, 7:00:00 PM)
352
-2.5 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners25.07%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap2.95B
Revenue(TTM)1.40B
Net Income(TTM)145.29M
Analysts82.67
Price Target410.04 (16.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP8.36%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.48%
PT rev (3m)2.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.3 | ||
| Fwd PE | 16.59 | ||
| P/S | 2.11 | ||
| P/FCF | 33.16 | ||
| P/OCF | 15.06 | ||
| P/B | 2.77 | ||
| P/tB | 5.14 | ||
| EV/EBITDA | 10.72 |
EPS(TTM)17.34
EY4.93%
EPS(NY)21.22
Fwd EY6.03%
FCF(TTM)10.61
FCFY3.02%
OCF(TTM)23.38
OCFY6.64%
SpS166.55
BVpS126.95
TBVpS68.53
PEG (NY)5.16
PEG (5Y)0.88
Graham Number222.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROCE | 16.54% | ||
| ROIC | 11.47% | ||
| ROICexc | 12.64% | ||
| ROICexgc | 20.66% | ||
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% | ||
| FCFM | 6.37% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
ROICexc(3y)14.41%
ROICexc(5y)15%
ROICexgc(3y)23.78%
ROICexgc(5y)25.77%
ROCE(3y)17.85%
ROCE(5y)17.84%
ROICexgc growth 3Y-15.04%
ROICexgc growth 5Y-5.22%
ROICexc growth 3Y-12.77%
ROICexc growth 5Y7.18%
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
F-Score7
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.65 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 166.78% | ||
| Cap/Sales | 7.66% | ||
| Interest Coverage | 45.59 | ||
| Cash Conversion | 66.89% | ||
| Profit Quality | 61.3% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 4.69 |
F-Score7
WACC7.74%
ROIC/WACC1.48
Cap/Depr(3y)125.08%
Cap/Depr(5y)109.34%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.5%
Profit Quality(3y)72.36%
Profit Quality(5y)71.26%
High Growth Momentum
Growth
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
EPS Next Y3.93%
EPS Next 2Y7.72%
EPS Next 3Y8.69%
EPS Next 5Y10.81%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
Revenue Next Year4.62%
Revenue Next 2Y4.99%
Revenue Next 3Y5.17%
Revenue Next 5Y5.53%
EBIT growth 1Y23.65%
EBIT growth 3Y10.61%
EBIT growth 5Y16.88%
EBIT Next Year33.24%
EBIT Next 3Y16.73%
EBIT Next 5Y14.59%
FCF growth 1Y6.41%
FCF growth 3Y29.91%
FCF growth 5Y10.8%
OCF growth 1Y46.26%
OCF growth 3Y26.32%
OCF growth 5Y14.75%
VIRBAC SA / VIRP.PA FAQ
What is the ChartMill fundamental rating of VIRBAC SA (VIRP.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA.
Can you provide the valuation status for VIRBAC SA?
ChartMill assigns a valuation rating of 4 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for VIRBAC SA?
VIRBAC SA (VIRP.PA) has a profitability rating of 6 / 10.
What is the expected EPS growth for VIRBAC SA (VIRP.PA) stock?
The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 3.93% in the next year.
How sustainable is the dividend of VIRBAC SA (VIRP.PA) stock?
The dividend rating of VIRBAC SA (VIRP.PA) is 2 / 10 and the dividend payout ratio is 8.36%.